Nature Biotechnology 24, 653 - 655 (2006)
doi:10.1038/nbt0606-653
The patentability of human embryonic stem cells in EuropeGerard Porter1, Chris Denning2, Aurora Plomer1, John Sinden3
& Paul Torremans11
University of Nottingham, School of Law, Nottingham NG7 2RD, UK. 2
University of Nottingham, Institute of Genetics, School of Biology, Queen's Medical Centre, Nottingham NG7 2UH, UK. 3
ReNeuron Group plc, 10 Nugent Road, Surrey Research Park, Guildford, Surrey GU2 7AF, UK. EUStemCellPatentProject@notting-ham.ac.uk
Applicants in Europe are left with few options for the patent protection of hES cell–related technology.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated.
|
